Skip to main content

Table 1 Cannabis patterns of use by decade in community-based athletes

From: Age related differences in cannabis use and subjective effects in a large population-based survey of adult athletes

Pattern of use Category 21 to 29 (n = 47) 30 to 39 (n = 74) 40 to 49 (n = 81) 50 to 59 (n = 61) ≥60 (n = 38) P value for trend
N (%)
Cannabinoid used THC 10 (21.3) 19 (25.7) 16 (19.8) 10 (16.4) 6 (15.8) 0.21
CBD 9 (19.1) 16 (21.6) 27 (33.3) 28 (45.9) 21 (55.3) < 0.001
THC and CBD 28 (59.6) 39 (52.7) 38 (46.9) 23 (37.7) 11 (28.9) 0.009
Reason for use Medical 4 (8.5) 15 (20.3) 28 (34.6) 31 (50.8) 21 (55.3) < 0.001
Recreational 21 (44.7) 23 (31.1) 23 (28.4) 15 (24.6) 5 (13.2) 0.002
Both 22 (46.8) 36 (48.6) 30 (37.0) 15 (24.6) 12 (31.6) 0.004
Duration > 3 years 30 (63.8) 41 (55.4) 37 (45.7) 21 (34.4) 18 (47.4) < 0.001
Frequency ≥4 times/week 12 (25.5) 39 (52.7) 33 (40.7) 20 (32.8) 13 (34.2) 0.20
Routes of administration Edible 31 (66.0) 38 (51.4) 46 (56.8) 18 (29.5) 14 (36.8) < 0.001
Vaporize 25 (53.2) 34 (45.9) 28 (34.6) 14 (23.0) 8 (21.1) < 0.001
Smoke 23 (48.9) 35 (47.3) 26 (32.1) 15 (24.6) 8 (21.1) < 0.001
Oil/tincture 17 (36.2) 24 (32.4) 35 (43.2) 31 (50.8) 23 (60.5) 0.003
Topical 15 (31.9) 23 (31.1) 29 (35.8) 22 (36.1) 13 (34.2) 0.57
Capsule 7 (14.9) 8 (10.8) 13 (16.0) 10 (16.4) 1 (2.6) 0.51
Spray 2 (4.3) 5 (6.8) 3 (3.7) 3 (4.9) 1 (2.6) 0.57
Routes of administration Edible 31 (66.0) 38 (51.4) 46 (56.8) 18 (29.5) 14 (36.8) < 0.001
Vaporize 25 (53.2) 34 (45.9) 28 (34.6) 14 (23.0) 8 (21.1) < 0.001
Smoke 23 (48.9) 35 (47.3) 26 (32.1) 15 (24.6) 8 (21.1) < 0.001
Oil/tincture 17 (36.2) 24 (32.4) 35 (43.2) 31 (50.8) 23 (60.5) 0.003
Topical 15 (31.9) 23 (31.1) 29 (35.8) 22 (36.1) 13 (34.2) 0.57
Capsule 7 (14.9) 8 (10.8) 13 (16.0) 10 (16.4) 1 (2.6) 0.51
Spray 2 (4.3) 5 (6.8) 3 (3.7) 3 (4.9) 1 (2.6) 0.57
Timing of use Within 1 h before starting exercise 14 (29.8) 25 (33.8) 21 (25.) 13 (21.3) 6 (15.8) < 0.001
During exercise 2 (4.3) 7 (9.5) 9 (11.1) 6 (9.8) 3 (7.9) 0.53
Within 1 h after finishing exercise 21 (44.7) 37 (50.0) 21 (25.9) 13 (21.3) 8 (21.1) < 0.001